This book contains WHO’s annual compilation of data from its 193 Member States, and includes a summary of progress towards the health-related Millennium Development Goals (MDGs) and targets. This edition also contains a new section on reported cases of selected infectious diseases. An online version of this publication and metadata describing the sources, estimation methods and the quality of estimates is available at http://www.who.int/statistics. The online version will be regularly updated as new data become available during 2009
This reference resource contains summaries of the NICE guideline on tuberculosis. It outlines key priorities and essential requirements for effective diagnosis, treatment and prevention of the disease
This report examines the epidemiological evidence on the burden and distribution of pneumonia and assesses current levels of treatment and prevention. The report aims to raise awareness of pneumonia and to serve as a call to action to reduce child deaths from pneumonia
Drawing from the collective knowledge and analytical work of the many experts who have contributed to this volume, this chapter provides a broader perspective on the relative efficiency and effect on health of a number of interventions than is possible in a single, condition-specific chapter. The objective is to provide information on the cost-effectiveness estimates for 319 interventions covering nearly every disease condition considered in the volume, and the resulting avertable burden of disease. This chapter provides broad conclusions on the economic efficiency of using these interventions to improve health.
What cost-effectiveness analysis (CEA) does and does not provide, how it is related to the concept of burden of disease, and how it can be used, along with other criteria, in setting priorities is discussed. The several meanings of the term CEA and the way that interventions are classified and evaluated are described. Estimating the effectiveness of an intervention requires specifying the units which in turn requires choices of several parameter values, including, in the analyses reported here, the discount rate applied to future years; the disability weights that describe the severity of diseases and conditions, corresponding to the health losses that they cause; and the life expectancy at different ages. Costs of interventions to include in the analysis, and conversion of costs to equivalents in U.S. dollars for international comparisons are described. Variations of results and uncertainty of estimates are discussed. Two ways are suggested to consider costs and outcomes at the population level, allowing for large differences among countries in the size of population; the incidence or prevalence of a disease, condition, or risk factor; and the amount spent or available to spend on an intervention
This publication brings together and updates the various guidelines produced by WHO over the years on sampling of specimens for laboratory investigation, identification of bacteria, and testing of antimicrobial resistance. It concentrates on the procedures to be followed, rather than the basic techniques of microscopy and staining, which have been described in detail in other WHO publications
JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and no cost for publication of research artcles making JIDC easily availiable to scientists from resource restricted regions
Source e-bulletin on Disability and Inclusion